Gene · 91746
Papers2,550
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,550
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinofibrate Disrupts the SNORA80B/YTHDC1-Driven M6A Modification to Suppress Cholesterol Metabolism and Cisplatin Resistance in ESCC. | Adv Sci (Weinh) | 2026 | 41178567 | PubTator, text mining | PubMed |
| The dysregulation of UPP1 incurred by METTL3 regulates the malignancy of esophageal squamous cell carcinoma in an m6A-YTHDC1-KLF5-mediated manner. | Cell Signal | 2026 | 41173378 | PubTator, text mining | PubMed |
| Role of lncRNA H19 modification (m6A methylation) and YTHDC1 in high glucose induced human microvascular endothelial cell biological behaviors. | Tissue Cell | 2026 | 41167000 | PubTator, text mining | PubMed |
| m6A-modified circCD2AP suppressed ferroptosis in bladder cancer by upregulating FOXC1 to promote PARK7 transcriptional activity. | Chin Med J (Engl) | 2026 | 40960159 | PubTator, text mining | PubMed |
| FAM20C Modulates Neuronal Differentiation in Hypoxic-Ischemic Brain Damage via KAP1 Phosphorylation and LINE1 RNA m6A-Dependent H3K9me3 Regulation. | Cell Prolif | 2026 | 40511628 | PubTator, text mining | PubMed |
| Nuclear m6A modification regulates satellite transcription and chromosome segregation. | Nat Chem Biol | 2026 | 40404899 | PubTator, text mining | PubMed |
| Expression and clinical value of key m6A RNA modification regulators in tuberculosis. | Front Immunol | 2025 | 41613118 | PubTator, text mining | PubMed |
| T-Cell-Driven Immunopathology and Fibrotic Remodeling in Hypertrophic Cardiomyopathy: A Translational Scoping Review. | Cells | 2025 | 41511345 | PubTator, text mining | PubMed |
| The METTL3-YTHDC1 axis mediates architectural RNA m6A modification to modulate the integrity of chromatin TADs in MLLr + AML genome. | Mol Cancer | 2025 | 41430607 | PubTator, text mining | PubMed |
| Xist in X chromosome inactivation: mechanisms and disease relevance. | Cell Commun Signal | 2025 | 41430272 | PubTator, text mining | PubMed |
| WDR3 drives pancreatic cancer metastasis by enhancing TGF-α mRNA stability through YTHDC1. | Am J Cancer Res | 2025 | 41395298 | PubTator, text mining | PubMed |
| The YTHDC1-m6A-MEG3 Regulatory Axis in Radiation-Induced Liver Injury: Deciphering Early-Stage Epitranscriptomic Alterations and Molecular Dynamics. | J Inflamm Res | 2025 | 41341215 | PubTator, text mining | PubMed |
| The RNA-binding protein RBM39 scaffolds an m⁶A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation. | PLoS Biol | 2025 | 41218081 | PubTator, text mining | PubMed |
| m6A-mediated silencing of RNF41 by METTL3/YTHDC1 disrupts autophagy to drive intervertebral disc degeneration. | Cell Biol Toxicol | 2025 | 41177830 | PubTator, text mining | PubMed |
Comprehensive Explorations and Preliminary Experimental Verification of RNA Modification-Related Diagnostic Markers in the Subtype Classification of Peripheral Blood-Derived Mononuclear Cells Derived from Post-Traumatic Stress Disorder Patients. | Diseases | 2025 | 41149057 | PubTator, text mining | PubMed |
| Prognostic genes related to mitochondrial dynamics and mitophagy in diffuse large B-cell lymphoma are identified and validated using an integrated analysis of bulk and single-cell RNA sequencing. | Front Immunol | 2025 | 41142795 | PubTator, text mining | PubMed |
| A PHF19-YTHDC1 condensate switches EZH2-mediated gene suppression to activation for prostate cancer progression. | Proc Natl Acad Sci U S A | 2025 | 41129231 | PubTator, text mining | PubMed |
| Identification of a novel m6A RNA methylation regulator-based signature for prognosis and immune landscape prediction in hepatocellular carcinoma. | Sci Rep | 2025 | 41120498 | PubTator, text mining | PubMed |
| Influenza NS1 drives N6-methyladenosine (m6A)-mediated autoregulation of viral mRNA splicing. | Emerg Microbes Infect | 2025 | 41066792 | PubTator, text mining | PubMed |
| ALKBH1 Gene rs6494 T>A Polymorphism Decreases Wilms Tumour Risk in Chinese Children. | J Cell Mol Med | 2025 | 41017026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/91746/papers?page=5